Skip to main content
Clinical Trials/NCT00731042
NCT00731042
Completed
Phase 4

A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects

Solventum US LLC0 sites33 target enrollmentMarch 2008

Overview

Phase
Phase 4
Intervention
Avagard
Conditions
Healthy
Sponsor
Solventum US LLC
Enrollment
33
Primary Endpoint
Change From Baseline in Skin Health, Visual Skin Score (VSS) at 14 Days
Status
Completed
Last Updated
last year

Overview

Brief Summary

Evaluate the effect of two hand antiseptic products on hand skin conditions of healthy volunteers.

Registry
clinicaltrials.gov
Start Date
March 2008
End Date
July 2008
Last Updated
last year
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Female age 25 - 55
  • Subject agrees not to use any hand wash products on their hands other than what has been provided in the study.
  • Subject agrees not to use any moisturizers or any skin products on their hands during the study
  • Subject agrees to use gloves to protect hands from activities such as dish washing
  • Subject is willing to sign the Informed Consent and HIPAA
  • Subject agrees to comply with the study requirement

Exclusion Criteria

  • Subject has a history of psoriasis, active dermatitis, skin reactions, cracked, irritated, broken skin, skin infection on their hands
  • Subject has scaly skin on hands based on Visual Scoring Scale at Day 1
  • Subject has a sensitivity or history of skin reactions to any study materials (eg, alcohol, chlorhexidine gluconate or zinc pyrithone or latex in the gloves)
  • Subject has been using moisturizing products or any products on their arms and hands within 5 days prior to participation in the study
  • Subject is pregnant
  • Study coordinator believes the subject is unsuitable for inclusion in the study

Arms & Interventions

Avagard

3M Avagard Surgical and healthcare Personnel Hand Antiseptic with Moisturizers

Intervention: Avagard

Purell

Purell Surgical Scrub with Moisturizers

Intervention: Purell Surgical Scrub

Outcomes

Primary Outcomes

Change From Baseline in Skin Health, Visual Skin Score (VSS) at 14 Days

Time Frame: Baseline and 14 days

Observe VSS score at 14 days, and graded change of skin health from baseline using scale of 0 (normal) - 5 (very scaly).

Similar Trials